Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23471820)

1.

TYK2-STAT1-BCL2 pathway dependence in T-cell acute lymphoblastic leukemia.

Sanda T, Tyner JW, Gutierrez A, Ngo VN, Glover J, Chang BH, Yost A, Ma W, Fleischman AG, Zhou W, Yang Y, Kleppe M, Ahn Y, Tatarek J, Kelliher MA, Neuberg DS, Levine RL, Moriggl R, Müller M, Gray NS, Jamieson CH, Weng AP, Staudt LM, Druker BJ, Look AT.

Cancer Discov. 2013 May;3(5):564-77. doi: 10.1158/2159-8290.CD-12-0504. Epub 2013 Mar 7.

2.

Discovering what makes STAT signaling TYK in T-ALL.

Fontan L, Melnick A.

Cancer Discov. 2013 May;3(5):494-6. doi: 10.1158/2159-8290.CD-13-0123.

3.

A novel requirement for Janus kinases as mediators of drug resistance induced by fibroblast growth factor-2 in human cancer cells.

Carmo CR, Lyons-Lewis J, Seckl MJ, Costa-Pereira AP.

PLoS One. 2011;6(5):e19861. doi: 10.1371/journal.pone.0019861. Epub 2011 May 20.

4.

JAK/STAT pathway plays a critical role in the proinflammatory gene expression and apoptosis of RAW264.7 cells induced by trichothecenes as DON and T-2 toxin.

Wang X, Liu Q, Ihsan A, Huang L, Dai M, Hao H, Cheng G, Liu Z, Wang Y, Yuan Z.

Toxicol Sci. 2012 Jun;127(2):412-24. doi: 10.1093/toxsci/kfs106. Epub 2012 Mar 27.

5.

JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.

Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL, Wolff RK.

Mol Carcinog. 2013 Feb;52(2):155-66. doi: 10.1002/mc.21841. Epub 2011 Nov 28.

7.

A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders.

Velusamy T, Kiel MJ, Sahasrabuddhe AA, Rolland D, Dixon CA, Bailey NG, Betz BL, Brown NA, Hristov AC, Wilcox RA, Miranda RN, Medeiros LJ, Jeon YK, Inamdar KV, Lim MS, Elenitoba-Johnson KS.

Blood. 2014 Dec 11;124(25):3768-71. doi: 10.1182/blood-2014-07-588434. Epub 2014 Oct 27.

PMID:
25349176
8.

Constitutive activation of STAT transcription factors in acute myelogenous leukemia.

Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F.

Eur J Haematol. 2001 Aug;67(2):63-71.

PMID:
11722592
10.

A small-molecule compound identified through a cell-based screening inhibits JAK/STAT pathway signaling in human cancer cells.

Kim BH, Yin CH, Guo Q, Bach EA, Lee H, Sandoval C, Jayabose S, Ulaczyk-Lesanko A, Hall DG, Baeg GH.

Mol Cancer Ther. 2008 Sep;7(9):2672-80. doi: 10.1158/1535-7163.MCT-08-0309.

11.

An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells.

Kamiya S, Owaki T, Morishima N, Fukai F, Mizuguchi J, Yoshimoto T.

J Immunol. 2004 Sep 15;173(6):3871-7.

12.

Selective JAK/STAT3 signalling regulates transcription of colony stimulating factor-2 and -3 in Concanavalin-A-activated mesenchymal stromal cells.

Zgheib A, Pelletier-Bonnier É, Levros LC Jr, Annabi B.

Cytokine. 2013 Aug;63(2):187-93. doi: 10.1016/j.cyto.2013.04.027. Epub 2013 May 17.

PMID:
23688618
13.
14.

Limitin, an interferon-like cytokine, transduces inhibitory signals on B-cell growth through activation of Tyk2, but not Stat1, followed by induction and nuclear translocation of Daxx.

Aoki K, Shimoda K, Oritani K, Matsuda T, Kamezaki K, Muromoto R, Numata A, Tamiya S, Haro T, Ishikawa F, Takase K, Yamamoto T, Yumioka T, Miyamoto T, Nagafuji K, Gondo H, Nagafuchi S, Nakayama K, Harada M.

Exp Hematol. 2003 Dec;31(12):1317-22.

PMID:
14662340
15.

Functional STAT3 deficiency compromises the generation of human T follicular helper cells.

Ma CS, Avery DT, Chan A, Batten M, Bustamante J, Boisson-Dupuis S, Arkwright PD, Kreins AY, Averbuch D, Engelhard D, Magdorf K, Kilic SS, Minegishi Y, Nonoyama S, French MA, Choo S, Smart JM, Peake J, Wong M, Gray P, Cook MC, Fulcher DA, Casanova JL, Deenick EK, Tangye SG.

Blood. 2012 Apr 26;119(17):3997-4008. doi: 10.1182/blood-2011-11-392985. Epub 2012 Mar 8.

16.

JAK and STAT proteins are expressed and activated by IFN-gamma in rat pancreatic acinar cells.

Gallmeier E, Schäfer C, Moubarak P, Tietz A, Plössl I, Huss R, Göke B, Wagner AC.

J Cell Physiol. 2005 Apr;203(1):209-16.

PMID:
15493010
17.

CP690,550 inhibits oncostatin M-induced JAK/STAT signaling pathway in rheumatoid synoviocytes.

Migita K, Komori A, Torigoshi T, Maeda Y, Izumi Y, Jiuchi Y, Miyashita T, Nakamura M, Motokawa S, Ishibashi H.

Arthritis Res Ther. 2011 May 6;13(3):R72. doi: 10.1186/ar3333.

19.

Tyk2 is a therapeutic target for psoriasis-like skin inflammation.

Ishizaki M, Muromoto R, Akimoto T, Sekine Y, Kon S, Diwan M, Maeda H, Togi S, Shimoda K, Oritani K, Matsuda T.

Int Immunol. 2014 May;26(5):257-67. doi: 10.1093/intimm/dxt062. Epub 2013 Dec 17.

PMID:
24345760
20.

STAT1-deficient mice are resistant to cecal ligation and puncture-induced septic shock.

Herzig D, Fang G, Toliver-Kinsky TE, Guo Y, Bohannon J, Sherwood ER.

Shock. 2012 Oct;38(4):395-402. doi: 10.1097/SHK.0b013e318265a2ab.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk